Coagulation Factor VIIa variant: Clinical Trials

2 trials of Coagulation Factor VIIa variant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Terminated 1

Follow Coagulation Factor VIIa variant: new trials by email Literature Review of Coagulation Factor VIIa variant trials Research Report on Coagulation Factor VIIa variant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders
Coagulation Factor VIIa variant - Factor VII Deficiency, Glanzmann Thrombasthenia
Phase 1 / Phase 2TerminatedCatalyst Biosciences192021-05-172021-12-21
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
Coagulation Factor VIIa variant - Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 2CompletedCatalyst Biosciences112017-12-182021-09-23

Conditions studied

Factor VII Deficiency (1)  ·  Thrombasthenia (1)

Sponsors

Catalyst Biosciences (2)

Countries

Russia (2)  ·  Armenia (1)  ·  Georgia (1)  ·  India (1)  ·  Italy (1)  ·  Poland (1)  ·  South Africa (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Howard Levy, MD, PhD, MMM (1)